USC-087 protects Syrian hamsters against lethal challenge with human species C adenoviruses.

about

USC-087 protects Syrian hamsters against lethal challenge with human species C adenoviruses.

Item

http://www.wikidata.org/entity/Q51730547

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

USC-087 protects Syrian hamste ...... human species C adenoviruses.

@en

USC-087 protects Syrian hamste ...... human species C adenoviruses.

@nl

type

Item

label

USC-087 protects Syrian hamste ...... human species C adenoviruses.

@en

USC-087 protects Syrian hamste ...... human species C adenoviruses.

@nl

prefLabel

USC-087 protects Syrian hamste ...... human species C adenoviruses.

@en

USC-087 protects Syrian hamste ...... human species C adenoviruses.

@nl

P1476

USC-087 protects Syrian hamste ...... h human species C adenoviruses

@en

P2093

Ann E Tollefson

http://www.w3.org/2001/XMLSchema#string

Baoling Ying

http://www.w3.org/2001/XMLSchema#string

Boris A Kashemirov

http://www.w3.org/2001/XMLSchema#string

Caroll B Hartline

http://www.w3.org/2001/XMLSchema#string

Charles E McKenna

http://www.w3.org/2001/XMLSchema#string

Cheryl Harteg

http://www.w3.org/2001/XMLSchema#string

Dawn Reyna

http://www.w3.org/2001/XMLSchema#string

Elke Lipka

http://www.w3.org/2001/XMLSchema#string

Eric T Richard

http://www.w3.org/2001/XMLSchema#string

Jacqueline F Spencer

http://www.w3.org/2001/XMLSchema#string

P2860

Outcomes of early administration of cidofovir in non-immunocompromised patients with severe adenovirus pneumonia

Clinical Features and Courses of Adenovirus Pneumonia in Healthy Young Adults during an Outbreak among Korean Military Personnel

Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir.

Adenovirus infections in immunocompetent and immunocompromised patients.

Adenoviral keratoconjunctivitis.

Ganciclovir inhibits human adenovirus replication and pathogenicity in permissive immunosuppressed Syrian hamsters.

Development of CMX001 for the Treatment of Poxvirus Infections.

A novel CDK7 inhibitor of the Pyrazolotriazine class exerts broad-spectrum antiviral activity at nanomolar concentrations.

Valganciclovir inhibits human adenovirus replication and pathology in permissive immunosuppressed female and male Syrian hamsters

Synthesis and early development of hexadecyloxypropylcidofovir: an oral antipoxvirus nucleoside phosphonate.

P304

1-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ANTIVIRAL.2018.03.001

http://www.w3.org/2001/XMLSchema#string

P478

153

http://www.w3.org/2001/XMLSchema#string

P50

Mark Prichard

P577

2018-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29510156

http://www.w3.org/2001/XMLSchema#string

P921

Adenoviridae

P932

5891362

http://www.w3.org/2001/XMLSchema#string